Company ProfilePremium

Revlon, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Revlon, Inc. - Food & Beverages showcase

Year Founded & Workforce

1932

5,600 Employees

Industry

Food & Beverages

Services

Revlon MascaraSun Protection ProductsRevlon
Revlon, Inc. logo

Revlon, Inc. Employee Contacts

6 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Revlon, Inc. Overview

Revlon is a 94-year-old American beauty house. Through a portfolio of more than 20 brands it makes and markets colour cosmetics, hair colour and care, fragrance, skin care, nail and personal-care products. Most of its volume goes through mass retail, led by Walmart, which accounted for ~14% of FY2022 sales. It also sells in prestige (Elizabeth Arden), professional salons (Revlon Professional, American Crew, CND) and a large owned-and-licensed fragrance business, now about a quarter of sales. Its brands are well known but under-invested. A decade of leveraged acquisitions, supply-chain failures and losses ended in a 2022–23 Chapter 11 reorganisation that handed control to credit funds. Under CEO Michelle Peluso since November 2024, the privately held group is running a brand-by-brand turnaround. The plan has three parts: sharpen brand identities (Revlon as "high-glam", Almay as clean drugstore makeup), expand aggressively in fragrance licensing, and rebuild the supply chain. Revenue has not been publicly reported since FY2022 ($1.98bn).


Company's own description (FY2022 10-K, Item 1). Revlon described itself as "a leading global beauty company with an iconic portfolio of brands." It said it develops, manufactures, markets, distributes and sells worldwide "an extensive array of beauty and personal care products." The list covered colour cosmetics, hair colour, hair care and treatments, fragrances, skin care, beauty tools, men's grooming, anti-perspirant deodorants and other beauty care, sold across a variety of channels. Its latest press boilerplate (Ice Spice launch release, 2026) describes it as "among the leading global beauty companies" with brands in colour cosmetics, skin care, hair colour, hair care and fragrance. The brands named are Revlon, Revlon Professional, Elizabeth Arden, Almay, Mitchum, American Crew, Creme of Nature, CND, Cutex, Juicy Couture, Elizabeth Taylor, Curve, John Varvatos, Christina Aguilera and Ice Spice.

Business model. Revlon is a branded consumer-packaged-goods manufacturer and marketer. Revenue is almost entirely product sales to retailers, distributors and salons. A small direct-to-consumer e-commerce stream runs through elizabetharden.com, americancrew.com, juicycouturebeauty.com and revlonprofessional.com. There is also a modest royalty stream: at 31 Dec 2022, eight licences of the Revlon trademark were in effect, covering more than 20 complementary product categories. No subscription or service revenue is disclosed. The fragrance business adds a licensing-in model. Revlon pays royalties to brand owners (Authentic Brands Group for Juicy Couture and Champion, celebrity licensors, Palm Angels) and also distributed about 27 third-party prestige fragrance brands (FY2022 10-K).

Revenue mix by product class (FY2022 10-K, Note 16). Colour cosmetics were 28% ($551.0M), fragrance 26% ($517.7M), hair care 23% ($451.9M), skin care 15% ($302.3M) and beauty care 8% ($157.5M).

Value-chain position. Revlon is vertically integrated from R&D through manufacturing to brand marketing. At FY2022 it had its own plants in the US (Oxford, North Carolina, its main and FDA-registered OTC drug facility; and Florida), Spain, Mexico, South Africa and Italy, supplemented by contract manufacturers in the US and Europe. Fragrance and some skin care rely more heavily on specialty third-party labs and manufacturers.

Customer types.

  • Mass retailers and drug chains: Walmart, CVS, Target, Walgreens, Kohl's, TJ Maxx/Marshalls.

  • Prestige and department stores: Macy's, Dillard's, Ulta, Belk, Sephora.

  • International chains: A.S. Watson, Boots, Superdrug, Shoppers Drug Mart, Douglas, Myer, The Perfume Shop.

  • Travel retail: Nuance, Heinemann, World Duty Free.

  • E-commerce platforms: Tmall in China.

  • Professional distributors: SalonCentric, Beauty Systems Group, Ulta Salon.

  • Individual salons and barbers.

Walmart and its affiliates were ~14% of net sales in both 2022 and 2021, and 18% in 2020.

End-markets. Mass colour cosmetics; mass hair colour; professional hair colour and care; men's grooming; professional nail (gel/Shellac); prestige skin care (notably China and travel retail for Elizabeth Arden); mass and prestige fragrance; deodorants (Mitchum).

Independent characterisation. Revlon is a sub-scale, multi-category beauty conglomerate. Its brand equity is greater than its financial capacity. Before bankruptcy it ran ~8,000 SKUs, many with 35–40 ingredients (Retail Dive, June 2022, citing CRO testimony). That complexity, combined with $3bn+ of debt, turned the 2021–22 supply shock into a liquidity crisis. The post-2023 model narrows priorities. Management is concentrating on fewer "right-to-win" brand positions, a fragrance licensing pipeline that is cheap to build and fast to launch, and supply-chain resilience. Mass shelf space (Walmart/Ulta/CVS) and China (Elizabeth Arden) remain the two most important commercial dependencies.

Strategy

Last filed strategy (FY2022 10-K). The company described three strategic pillars:

  1. Strengthening its iconic brands through innovation and relevant product portfolios.

  2. Building capabilities to communicate and connect with consumers where they spend the most time.

  3. Ensuring availability of products where consumers shop, in-store and increasingly online.

These sat alongside the RGGA cost programme (rightsizing for profitability, cash flow and liquidity).

Current strategy (Peluso era, 2024–2026), as articulated in interviews (Glossy, Feb 2026; WWD/MEXC, Nov 2025):

  1. Narrow, distinct brand identities. The approach is brand-by-brand demand mapping of where Revlon has a right to win. Revlon is repositioned to "high-glam, high-impact"; Peluso admitted past drift toward "no-makeup makeup". Almay is aimed at clean drugstore makeup. The PhotoReady relaunch (Feb 2026) targets Gen Z, and Peluso says the changes have already won more shelf space at some mass retailers.

  2. Aggressive fragrance expansion. Fragrance is ~25% of sales. Initiatives include:

    • Ice Spice licence (launched 2026)

    • Christina Aguilera renewal (new scent 2026)

    • Juicy Couture renewal and new Just Moi formats

    • Champion (2027) and Palm Angels (2027) licences

    • Elizabeth Arden Eternal Aura (2026) Peluso called the Ice Spice deal "a major step in the revitalization of Revlon's fragrance business".

  3. Supply-chain redesign. A "reframing" of the global supply chain and of China's role, including local R&D in China for Elizabeth Arden.

  4. Data, digital and culture. A new CIDO and an emphasis on data-led consumer insight and accountability culture (WWD, Nov 2025).

  5. R&D consolidation. The New Jersey lab moves to the NEST Center campus.

ESG / sustainability commitments. No post-2023 targets publicly disclosed.

Cost programmes. The pre-bankruptcy RGGA targeted up to $230M of annual savings by end-2022. Post-emergence cost targets are not publicly disclosed.

Medium-term targets and guidance. None published. As a private company Revlon issues no guidance. Bankruptcy-plan projections (2023 Disclosure Statement) existed but are now stale.

Products & Services

Pricing is not publicly disclosed at company level. Revlon describes its mass colour cosmetics as "principally priced in the upper range for large volume retailers" (FY2022 10-K).

Revlon segment

Brand / lineDescription & key capabilitiesTarget customerLatest version / yearFlagship offerings
Revlon (colour cosmetics)Face, lip, eye and nail makeup. Repositioned in 2025–26 as "high-glam, high-impact"; the CEO says it is "not a brand for 'no-makeup makeup'" (Glossy, Feb 2026)Mass-market women; Gen Z targeted in relaunches"Most Unforgettable Women in the World Wear Revlon" iteration of the "Be Unforgettable" campaign (Happi)Super Lustrous lipstick
Revlon ColorStayLong-wear technology across face, lip, eye and nailLong-wear seekersOngoingColorStay foundation
Revlon PhotoReadyPhotochromatic pigments for an airbrushed lookGen Z / social-content creatorsRelaunched Feb 2026 with new packaging, shades and formulas (Glossy)PhotoReady face and eye
Revlon Age DefyingFace makeup for the over-35 bracket with anti-wrinkle ingredients35+ womenOngoingAge Defying foundation
Revlon Ultra HDLiquid lip colour; one-coat vegan "20-free" nail colourMassOngoingUltra HD Matte Lip
Revlon So FierceTrend-forward eyeliner, mascara and shadowBold-look consumersOngoingSo Fierce eyeliner
Revlon ColorSilkMass at-home hair colour and careMass at-home colourersOngoingColorSilk Beautiful Color
Revlon ProfessionalSalon-exclusive hair colour, care and treatment in 85+ countriesSalon professionalsColor Excel by Revlonissimo Tone on Tone (ammonia-free demi-permanent) promoted 2026 (Behindthechair)Revlonissimo, Eksperience, Nutri Color Creme, UniqOne, Equave
Revlon beauty toolsNail, eye, skin and grooming tools, lash curlers, brushesMassOngoingTweezers, lash curlers
Revlon licensed products8 trademark licences across 20+ categories (FY2022)MassOngoingRevlon-branded hair appliances (licensed category; licensee not named in filings)

Elizabeth Arden segment

Brand / lineDescriptionTargetLatestFlagship
CeramideBarrier and anti-ageing skin care (capsules, retinol ceramide, eye)Prestige 35+Retinol Ceramide line extensions (Beauty Packaging 2022/23)Ceramide Capsules
PrevageIdebenone-based anti-ageing (proprietary/patented technology per 10-K)Prestige anti-ageingAnti-Aging Eye Serum 2.0Prevage serum
Eight HourMulti-purpose balm franchiseBroad prestigeOngoingEight Hour Cream
SUPERSTARTSkin-renewal boostersPrestigeOngoingSUPERSTART booster
Visible DifferenceMoisturisersPrestige / masstigeOngoingRefining Moisture Cream
Skin Illuminating / Elizabeth Arden ProBrightening; professional channelPrestige / spaOngoing—
Red Door, 5th Avenue, White Tea, Green Tea, Always RedOwned Arden fragrances; tea collections grew double-digit in 2021Prestige / masstigeEternal Aura new scent planned for 2026 (Glossy)Red Door, Green Tea
Arden colour cosmeticsPrestige makeupPrestigeOngoing—
Virtual storeImmersive e-commerce store with Obsess (May 2023)Digital shoppers2,023—

China is a key growth market. Revlon set up a local R&D facility because Elizabeth Arden is a "powerhouse brand in China" (Peluso, Glossy, Feb 2026).

Portfolio segment

BrandDescriptionTargetNotes
AlmayHypo-allergenic, fragrance-free cosmetics and removers (Smart Shade, Intense Eye Color, Color + Care)Sensitive-skin / clean drugstoreCEO says Almay has a "right to win" in clean drugstore makeup (Glossy, 2026)
SinfulColorsValue nail enamels in bold coloursValue mass—
CutexNail polish remover and careMass—
CNDProfessional nail enhancement; Shellac 14+ day gel system; Vinylux weekly polish (light-curing, patent-pending); spaNail salons, 50+ countriesShellac system relaunched with CND Visible Light lamp, which cures without UV or LED (Happi)
American CrewMen's styling, care and shave for salons and barbers; "Official Supplier to Men"; 70+ countries plus DTCMen / barbers2020 launches: Lather Shave Cream, Finishing Spray, Detox Shampoo
d:fiValue unisex stylingYoung mass—
MitchumAnti-perspirant deodorants with patented 48-hour protectionMen and women, mass—
Creme of NatureMulticultural hair care (salon and retail), US-centredTextured-hair consumersExposed to hair-relaxer litigation category (see Section 19)
Orofluido / IntercosmoProfessional hair careSalons (Spain/Europe)—
Llongueras (licensed)Premium hair colour, SpainSpanish massLicensed from a third party

Fragrances segment (≈25% of company sales, 2026)

BrandOwnershipPositioningStatus
Juicy Couture (Just Moi, Viva la Juicy)Licensed from Authentic Brands Group since 2016; renewed 2025Prestige / Gen ZNew Just Moi formats teased (Glossy, 2026)
Ice Spice "In Ha Mood"Global licence; first Ice Spice fragranceGen Z celebrityLaunched 2026 at Ulta. Floral fruity amber EDP with "Queen Royale Accord" (berry fizz, pear, wild raspberry) and an emerald-cut cap (GCI / PR Newswire)
Christina AguileraLicence renewed (10+ year partnership: Signature, Definition, By Night)CelebrityNew scent aimed at younger consumers in 2026 (GCI)
Elizabeth Taylor (White Diamonds)Licensed / owned mark mix per 10-KHeritageOngoing
Britney SpearsLicensedCelebrityStatus after 2023 not confirmed in sources reviewed
John VarvatosLicensedPrestige men'sOngoing
ChampionNew global licence via Authentic Brands Group (2025)Sport / lifestyleFirst fragrance due 2027
Palm AngelsNew licenceLuxury streetwearScents due 2027 (Glossy)
Curve, Charlie, Halston, Giorgio Beverly Hills, Jean Naté, PS, Geoffrey Beene, Lucky Brand, Ed Hardy, Alfred SungOwned or licensed mass fragranceMass / valueOngoing
AllSaints, Jennifer AnistonLicensed—Licences rejected or expired by 31 Dec 2022 (FY2022 10-K)
Third-party distribution~27 prestige brands owned by othersDistributionFY2022

Fragrance leadership: former Estée Lauder executive Amber Garrison leads the fragrance expansion (Clay company profile, 2026; corroborate with company sources).

Financial Narrative

Scope. The five most recent audited fiscal years publicly available are FY2018–FY2022. Full statement detail was retrieved for FY2019–FY2022 (FY2020 and FY2022 10-Ks). FY2018 revenue and net loss come from Revlon's reported comparatives. FY2023–FY2025: not publicly disclosed. The only post-emergence datapoints are Q1 2023 net sales of $490.0M (vs $479.6M in Q1 2022) and ~$1.5bn of debt at emergence (Reuters, May 2023). The Glossy (Feb 2026) reference to "just over $2 billion" relates to 2021.

Margins (%; calculated)

Revenue CAGR. FY2018–FY2022 was -6.3% a year; FY2019–FY2022 was -6.5% a year.

Commentary.

FY2019: Net sales fell 5.6% as the core Revlon colour business lost share to digitally native and celebrity brands. Operating income was barely positive ($60.7M), flattered by a $26.6M gain on divested assets.

FY2020: COVID cost an estimated $505M of sales. The year also carried a $144.1M impairment and a $158.8M tax charge, largely deferred-tax valuation allowances, which together produced a $619M loss. Within that, e-commerce rose ~40% to 16% of sales.

FY2021: The recovery year: sales +9.2% and gross margin at a peak of 59.2%. Interest of $247.7M still consumed more than twice operating income.

FY2022: Supply-chain shortages, $85.8M of FX headwind and $416.0M of reorganisation items produced the largest loss of the period. Adjusted EBITDA fell 11.1% to $260.3M.

The structural inflection is clear. Even in the best year, Adjusted EBITDA (≈$293M) only modestly exceeded cash interest (≈$242M paid in FY2021), so the capital structure, not the operations, set the outcome.

Balance sheet

FY2022 note: prepetition debt was reclassified into "liabilities subject to compromise" ($3,711.2M). FY2022 funded-debt and net-debt figures therefore cover mainly the DIP facilities and are not comparable with prior years. At filing the prepetition facilities included:

  • 2016 Term Loan: $872.4M

  • 2020 BrandCo facilities: $1,878.0M

  • Amended 2016 ABL / FILO / SISO: $289.0M

  • 6.25% Senior Notes due 2024: $431.3M

(Source: FY2022 10-K, Item 1.)

Cash flow

The only equity outflows were tax withholding on RSU settlements: $1.6M (2019), $1.7M (2020), $2.4M (2021) and $3.3M (2022). FY2022 OCF also absorbed $152.0M of cash reorganisation items and a $61.2M inventory build.

Commentary. Revlon did not generate positive free cash flow in any of the four years. Cash interest of roughly $195–242M a year exceeded the gap between Adjusted EBITDA and working-capital needs. Capex was cut to ~0.5–0.7% of sales, below the 2–4% typical for beauty peers. That signals under-investment in the plants whose failures later contributed to the bankruptcy: Oxford, NC, Florida and Mexico facilities had closed or were weeks from closing for lack of supply at filing (Retail Dive, June 2022).

Ratios (calculated from 10-K data)

ROE and debt/equity are not meaningful because stockholders' equity was negative in every year. The FY2022 DPO collapse to 55 days reflects suppliers tightening terms ahead of and during the bankruptcy, the "deadly cycle" described in court filings. Post-emergence supplier data from Dun & Bradstreet show days-beyond-terms of 5–16 between Sep 2024 and Aug 2025, mostly below industry averages. Roughly 25%–37% of supplier payments were 1–30 days late in Jan–Aug 2025, with spikes in April (11) and May 2025 (16) (CosmeticsDesign, Oct 2025). This is a partial read on post-reorganisation liquidity discipline.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsPrincipal channels

Revlon

Revlon colour cosmetics (ColorStay, PhotoReady, Age Defying, Ultra HD, Super Lustrous, So Fierce), Revlon ColorSilk hair colour, Revlon Professional salon hair colour and care, Revlon beauty tools

Mass, drug, food, e-commerce, TV shopping, salons, ~150 countries

Elizabeth Arden

Skin care (Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference, Skin Illuminating, Elizabeth Arden Pro), Arden fragrances (Red Door, 5th Avenue, White Tea, Green Tea, Always Red), colour cosmetics

Prestige, department stores, perfumeries, travel retail, Tmall/China, DTC

Portfolio

Almay, SinfulColors, Cutex, CND (Shellac, Vinylux), American Crew, d:fi, Mitchum, Creme of Nature, Orofluido, Intercosmo, Llongueras (licensed, Spain)

Mass, salons, barbers, professional distributors

Fragrances

Owned mass fragrances (Charlie, Curve, Giorgio Beverly Hills, Halston, Jean Naté, PS, White Diamonds) plus licensed prestige/celebrity brands (Juicy Couture, John Varvatos, Britney Spears, Christina Aguilera, Elizabeth Taylor, Ed Hardy, Lucky Brand, Alfred Sung, Geoffrey Beene) and ~27 third-party distributed brands

Prestige, mass, travel retail, e-commerce

Revenue by Segment

SegmentFY2019FY2020FY2021FY2022

Revlon segment net sales (USD Mn)

958.8688.4727.9752.6

Elizabeth Arden segment net sales (USD Mn)

520.0463.5532.3509.7

Portfolio segment net sales (USD Mn)

487.8401.3419.1373.4

Fragrances segment net sales (USD Mn)

453.0351.1399.4344.7

Total net sales (USD Mn)

2,419.61,904.32,078.71,980.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment

SegmentFY2019FY2020FY2021FY2022

Revlon segment profit (USD Mn)

101.286.586.889.0

Elizabeth Arden segment profit (USD Mn)

37.639.662.861.7

Portfolio segment profit (USD Mn)

45.047.471.050.4

Fragrances segment profit (USD Mn)

82.366.672.359.2

Total segment profit (USD Mn)

266.1240.1292.9260.3

Segment Margins & Growth (%)

SegmentFY2019FY2020FY2021FY2022

Revlon margin (%)

10.612.611.911.8

Elizabeth Arden margin (%)

7.28.511.812.1

Portfolio margin (%)

9.211.816.913.5

Fragrances margin (%)

18.219.018.117.2

Group segment-profit margin (%)

11.012.614.113.1

Segment Revenue

SegmentFY2020 YoY (%)FY2021 YoY (%)FY2022 YoY (%)FY2022 share of sales (%)

Revlon

-28.25.73.438.0

Elizabeth Arden

-10.914.8-4.225.7

Portfolio

-17.74.4-10.918.9

Fragrances

-22.513.8-13.717.4

Income Statement

MetricFY2018FY2019FY2020FY2021FY2022

Net sales (USD Mn)

2,564.52,419.61,904.32,078.71,980.4

Net income (loss) (USD Mn)

-294.2-157.7-619.0-206.9-673.9

Income Statement and Per-Share Data

MetricFY2019FY2020FY2021FY2022

Cost of sales (USD Mn)

1,052.2860.5849.1835.7

Gross profit (USD Mn)

1,367.41,043.81,229.61,144.7

SG&A (USD Mn)

1,316.61,071.81,099.11,033.1

Restructuring charges and other (USD Mn)

12.849.726.16.5

Impairment charges (USD Mn)

0.0144.10.024.3

Operating income (loss) (USD Mn)

60.7-226.3103.279.9

Depreciation and amortisation (USD Mn)

162.9143.3125.7105.7

EBITDA, reported (op. income + D&A) (USD Mn)

223.6-83.0228.9185.6

Adjusted EBITDA / total segment profit (USD Mn)

266.1240.1292.9260.3

Interest expense, net (USD Mn)

196.6243.3247.7252.9

Reorganisation items, net (USD Mn)

0.00.00.0416.0

Pre-tax income (loss), continuing ops (USD Mn)

-165.0-460.2-200.7-642.2

Income tax provision (USD Mn)

0.2158.86.231.7

Net income (loss) (USD Mn)

-157.7-619.0-206.9-673.9

Basic and diluted EPS (USD)

-2.97-11.59-3.84-12.28

Dividends per share (USD)

0000

Margin Analysis (%)

MetricFY2019FY2020FY2021FY2022

Gross margin (%)

56.554.859.257.8

Operating margin (%)

2.5-11.95.04.0

Reported EBITDA margin (%)

9.2-4.411.09.4

Adjusted EBITDA margin (%)

11.012.614.113.1

Net margin (%)

-6.5-32.5-10.0-34.0

Balance Sheet

MetricFY2019FY2020FY2021FY2022

Total assets (USD Mn)

2,980.62,527.72,432.52,489.8

Cash and equivalents (USD Mn)

104.397.1102.4249.3

Trade receivables (USD Mn)

423.4352.3383.8352.7

Inventories (USD Mn)

448.4462.6417.4469.3

Short-term debt incl. current LTD (USD Mn)

290.2220.0137.9747.1

Long-term debt (USD Mn)

2,906.23,105.03,305.50.1

Total funded debt on balance sheet (USD Mn)

3,196.43,325.03,443.4747.2

Net debt (USD Mn)

3,092.13,227.93,341.0497.9

Liabilities subject to compromise (USD Mn)

0.00.00.03,711.2

Stockholders' equity (deficiency) (USD Mn)

-1,221.2-1,862.0-2,014.1-2,662.7

Goodwill (USD Mn)

673.7563.7562.8562.2

Intangible assets, net (USD Mn)

490.7430.8392.2334.1

Goodwill and intangibles (USD Mn)

1,164.4994.5955.0896.3

Working capital (current assets less current liabilities) (USD Mn)

154.5202.2252.0-48.5

Cash Flow

MetricFY2019FY2020FY2021FY2022

Operating cash flow (USD Mn)

-68.3-97.3-11.0-243.5

Capital expenditures (USD Mn)

29.010.314.213.8

Free cash flow (OCF less capex) (USD Mn)

-97.3-107.6-25.2-257.3

Permanent display purchases, within OCF (USD Mn)

46.230.824.928.1

Cash interest paid (USD Mn)

194.6238.6241.5213.3

Dividends paid (USD Mn)

0000

Share buybacks (USD Mn)

0000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2019FY2020FY2021FY2022

ROA, net income / year-end assets (%)

-5.3-24.5-8.5-27.1

ROIC, op. income × (1-25% notional tax) / (net debt + equity) (%)

2.4-12.45.8—

Current ratio (x)

1.161.241.320.96

Net debt / Adjusted EBITDA (x)

11.613.411.4—

Interest coverage, EBIT / interest (x)

0.31-0.930.420.32

Adjusted EBITDA / interest (x)

1.350.991.181.03

Asset turnover, sales / year-end assets (x)

0.810.750.850.80

DSO (days)

63.967.567.465.0

DIO (days, on cost of sales)

155.5196.2179.4205.0

DPO (days, on cost of sales)

87.386.293.655.0

Cash conversion cycle (days)

132.1177.5153.2215.0

Revenue by Region

RegionFY2020FY2022

North America net sales (USD Mn, ±1)

986973

EMEA net sales (USD Mn, ±1)

434470

Asia net sales (USD Mn, ±1)

302323

Latin America net sales (USD Mn)

77.6100.7

Pacific net sales (USD Mn)

103.0112.0

Total net sales (USD Mn)

1,904.31,980.4

Segment Overview — Revlon

SegmentNorth AmericaEMEAAsiaLatin AmericaPacificTotal

Revlon

~413

~166

37.966.568.4752.6

Elizabeth Arden

97.8

~123

~265

5.618.0509.7

Portfolio

~237

~103

2.216.913.3373.4

Fragrances

225.677.217.911.712.3344.7

Valuation Snapshot

MetricValue

Share price performance (1/3/5-year)

Not applicable (private). Historical: equity value went to zero under the Plan

Last NYSE trading

20 Oct 2022 (suspension)

Shares outstanding at 31 Dec 2022

54,302,001 Class A

Non-affiliate market value at 30 Jun 2022

~$43.7M

P/E, EV/EBITDA, EV/Sales, P/B

Not applicable / not publicly disclosed

Analyst consensus

None (no equity coverage)

Dividends

None in FY2018–FY2022; none expected (Plan risk factors stated no dividends on new securities)

Capital Markets Data

MetricFY2018FY2019FY2020FY2021FY2022

Net sales (USD Mn)

2,564.52,419.61,904.32,078.71,980.4

Capital Markets

ItemDetail

Moody's / S&P / Fitch ratings

Current corporate and facility ratings not publicly confirmed in sources reviewed. Pre-bankruptcy ratings were deep speculative grade, with S&P noting reliance on MacAndrews & Forbes support (Fortune, 2019)

Debt at emergence

~$1.5bn (Reuters, May 2023), comprising exit term loan and ABL facilities plus a $200M incremental new-money first-lien commitment (Debt Commitment Letter, Jan 2023)

Liquidity at emergence

~$236M

Equity raised at emergence

$670M rights offering (backstopped)

Pre-petition reference (FY2022 10-K)

2016 Term Loan $872.4M; BrandCo $1,878.0M; ABL/FILO/SISO $289.0M; 6.25% Notes due 2024 $431.3M

Analyst Conclusions

Management guidance. None published; Revlon is private and issues no guidance. Management's qualitative messages (Glossy, Feb 2026; WWD, Nov 2025) point to the "next chapter of growth" through fragrance expansion, sharper brand identities, a redesigned supply chain and a data-led culture.

Consensus growth expectations. None (no analyst coverage).

Bull case

  1. Fragrance flywheel. Fragrance is already ~25% of sales and historically the highest-margin segment (17–19%). A pipeline of four new or renewed licences (Ice Spice 2026, Aguilera 2026, Champion 2027, Palm Angels 2027) plus Arden's Eternal Aura could mix group margins upward.

  2. Fixed capital structure. With >$2.7bn of debt removed, FY2021-level Adjusted EBITDA (~$293M) would leave cash after interest for the brand investment Revlon could never afford, given capex of only 0.5–1.2% of sales historically.

  3. Optionality on exit. Separable, recognisable assets (Elizabeth Arden in China, CND, American Crew, Juicy Couture fragrance) give credit-fund owners several monetisation routes.

Bear case

  1. Mass colour remains structurally challenged. Revlon-brand North America sales fell >10% in 2018, and e.l.f., L'Oréal and private label continue to take share. The PhotoReady relaunch is a small step against much larger competitors.

  2. Operational fragility persists. The CCC was 215 days (FY2022), supplier payments were still 25–37% late in early-to-mid 2025, and production is concentrated in a few plants. A new supply shock could again strain liquidity.

  3. Leverage is still meaningful and opaque. At roughly 5.8x pre-improvement leverage with no public reporting, there is limited evidence the turnaround is earning out. Licence-driven fragrance growth can reverse if celebrity launches underperform.

Catalysts and monitorables (next 12 months)

  • Ice Spice "In Ha Mood" sell-through at Ulta and any expansion into international and mass distribution.

  • Christina Aguilera and Elizabeth Arden Eternal Aura launches (2026) and Champion and Palm Angels readiness (2027).

  • Evidence of shelf-space gains for the repositioned Revlon brand at Walmart, CVS and Ulta.

  • Any refinancing, ratings action or owner-led sale process. Credit funds' typical hold periods make a 2026–2028 exit plausible, though nothing has been announced.

  • Hair-relaxer MDL developments and any residual exposure for the reorganised entity.

  • Executive stability: CFO and CSTO tenure since 2023, and the board chair after Smith.

  • Completion of the R&D relocation to the NEST campus and China R&D output.

Analyst verdict. Revlon in 2026 is a credit-fund-owned turnaround of a heritage beauty franchise. Its last audited numbers (FY2022: $1.98bn sales, 57.8% gross margin, $260M Adjusted EBITDA, -$257M free cash flow) describe a company whose operations were sound enough to survive but whose capital structure was not. The 2023 reorganisation fixed the most urgent problem by cutting debt from roughly $3.4bn of funded borrowings to about $1.5bn. It did not by itself fix the operating gaps: under-investment, slow working capital, customer concentration and a fading mass-colour brand.

The Peluso agenda is credible and well sequenced. It starts with the cheapest, fastest lever, fragrance licensing, where Revlon has proven infrastructure and the highest historical segment margin. Next comes brand clarity for Revlon and Almay, aimed at recovering mass shelf space, alongside a supply chain rebuilt for resilience. The 2025–26 execution evidence is real but early: four licences signed or renewed, a PhotoReady relaunch, a national Ice Spice launch at Ulta and a strengthened executive bench. The financial evidence is largely absent. No revenue, EBITDA or leverage figure has been published since 2022, and supplier-payment data show a company that is managing liquidity rather than enjoying a surplus.

On balance, Revlon looks like a stabilised, modestly improving business. Its value depends on whether the fragrance-led mix shift can lift Adjusted EBITDA margins sustainably above the ~13–14% achieved in FY2021–22, and whether its owners can then refinance or exit at a valuation that repays their conversion of debt into equity. For counterparties (suppliers, licensors, retailers), we judge credit risk elevated but much lower than in 2022. For prospective acquirers, the most attractive pieces are probably Elizabeth Arden (China skin care), CND and the fragrance licence book rather than the namesake mass colour business. Our view is cautiously constructive on direction and low-confidence on magnitude until the company resumes financial disclosure.


Principal sources

  • Revlon, Inc. Form 10-K FY2022 (filed 17 Mar 2023) and XBRL R-pages R3, R5, R9, R33, R57 — SEC EDGAR CIK 887921

  • Revlon, Inc. Form 10-K FY2020 (filed 11 Mar 2021) and XBRL R2, R4, R8, R46

  • Revlon Q4/FY2022 results release (Business Wire, 15 Mar 2023)

  • Reuters, "Revlon emerges from bankruptcy after lender takeover" (2 May 2023); ABL Advisor, FashionUnited, Cosmetics Business, Beauty Packaging emergence coverage (May 2023)

  • Retail Dive (Revlon hires Peluso, Oct 2024; supply-chain bankruptcy, Jun 2022; RSA, Mar 2023; sale exploration, 2019)

  • FashionNetwork (Peluso appointment, Oct 2024; Marshall CIDO, Mar 2025; refinancing, May 2020)

  • FashionUnited (Medema, Apr 2025)

  • Happi top-company profile (Revlon); Happi (Aug 2023 executive hires; Ice Spice licence)

  • Glossy, "3 standout strategies driving Revlon's 2026 comeback plan" (23 Feb 2026)

  • GCI Magazine / Cosmetics & Toiletries company pages (Champion, Aguilera, Juicy Couture, NEST lab); GCI / PR Newswire (Ice Spice "In Ha Mood" launch, 2026)

  • CosmeticsDesign, "Financial Focus: Revlon's path to revival" (23 Oct 2025)

  • Gulf News/Reuters, City A.M., Business of Fashion (Elizabeth Arden deal, 2016); Fortune and Industry Week (2019 strategic review)

  • Behindthechair (Revlon Professional Color Excel, 2026); Snov.io and Clay company profiles (2026; used only for low-weight context)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleSincePrior rolesEducation / age

Michelle Peluso

Chief Executive Officer; board member

4 Nov 2024

CVS Health EVP and Chief Customer & Experience Officer (also described as co-president, CVS Pharmacy); Global CMO at IBM and Citi; CEO of Travelocity and Gilt; Nike board director

—

Ted McCormick

Chief Financial Officer

5 Sep 2023

CFO RealTruck (2021–23); CFO The Bountiful Company (sold by KKR to Nestlé); ~two decades at Unilever, including CFO of Ben & Jerry's and the Pepsi Lipton Partnership

Not disclosed. Still in role as of latest sources? Not re-confirmed in 2026

Will Cornock

Chief Strategy & Transformation Officer

5 Sep 2023

Partner, Boston Consulting Group

Not disclosed. Current status not re-confirmed

Dana Medema

President, North America

5 May 2025

SVP and Head of Personal Health North America, Philips; ~20 years at Colgate-Palmolive

—

Ralph Marshall

Chief Information & Digital Officer

1 Apr 2025

Global CTO, Merlin Entertainments; VP Technology EMEA, Starbucks; McDonald's IT Europe

—

David Schwartz

General Counsel

Appointed in a February (year not specified in Happi profile; likely 2025)

——

Amber Garrison

Head of fragrance expansion (title not confirmed)

2025–2026 (approx.)

Former Estée Lauder executive

—

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

Aug 2023

Debra Perelman steps down as CEO; Liz Smith interim CEO

Ended Perelman-family management after emergence

5 Sep 2023

McCormick (CFO), Breig (President NA), Cornock (CSTO) join

Post-bankruptcy professionalisation

4 Nov 2024

Michelle Peluso becomes CEO

Permanent CEO after more than a year of interim leadership

1 Apr 2025

Ralph Marshall replaces CIO Paul Smith as CIDO

Digital and data capability (Peluso: "make sure we've got the data right")

5 May 2025

Dana Medema replaces Geralyn Breig as President NA

Breig credited with the post-bankruptcy North America turnaround

Feb (2025, approx.)

David Schwartz appointed General Counsel

—

Major Shareholders

HolderStake

Glendon Capital Management

Not publicly disclosed (lead owner group member)

Competitive Landscape

Competitors by Segment

SegmentDirect competitors

Mass colour (Revlon, Almay)

L'Oréal (Maybelline, L'Oréal Paris, NYX), Coty (CoverGirl, Rimmel, Max Factor), e.l.f. Beauty, Markwins, private label

Hair colour and care

L'Oréal (Excellence, L'Oréal Professionnel), Henkel (Schwarzkopf), Coty (Wella stake), Kao (Goldwell), Unilever

Prestige skin care (Elizabeth Arden)

Estée Lauder, Shiseido, L'Oréal Luxe, AmorePacific, LG H&H, Beiersdorf

Professional nail (CND)

Hand & Nail Harmony (Gelish), OPI (Wella), Kiara Sky

Men's grooming (American Crew)

L'Oréal, Henkel, P&G, Unilever

Fragrance

Coty, Puig, Interparfums, L'Oréal Luxe, Estée Lauder, Parlux, Elizabeth Arden peers in celebrity fragrance

Deodorant (Mitchum)

P&G (Secret, Old Spice), Unilever (Dove, Degree), Beiersdorf (Nivea)

Digital-native challengers

Fenty Beauty, Kylie Cosmetics, Glossier, Anastasia Beverly Hills, Too Faced, Benefit

Peer Comparison FY2025

MetricRevlon (FY2022)L'Oréal (FY2024)Coty (FY2025, June YE)e.l.f. Beauty (FY2025, March YE)

Revenue

$1.98bn

~€43.5bn

~$5.9bn

~$1.3bn

Revenue growth

-4.7%

~+5.6%

~-4%

~+28%

Gross margin

57.8%

~74%

~64%

~71%

Adj. EBITDA / operating margin

13.1% adj. EBITDA

~20% operating

~17–18% adj. EBITDA

~22% adj. EBITDA

R&D intensity

Not disclosed (~200 R&D staff)

~3% of sales

~1–2% (approx.)

Not material / not disclosed

Recent Developments

As a private company Revlon publishes limited news. Items with uncertain exact dates are marked "approx."

Company Snapshot

$2,419.6M

Revenue

5,600

Employees

1932

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

  • Brand heritage. 94 years of history; trademarks registered in about 150 countries (FY2022 10-K).
  • Diversified category mix. No product class above 28% of sales (FY2022: colour 28%, fragrance 26%, hair 23%, skin 15%, beauty care 8%).
  • Resilient gross margin. 54.8%–59.2% across FY2019–FY2022, even during COVID and supply shocks.
  • Elizabeth Arden's China franchise. Arden Asia sales of ~$265M and segment margin rising from 7.2% to 12.1% (FY2019–FY2022).
  • Fragrance licensing capability. Fragrances was the highest-margin segment (17–19%), with four new or renewed licences in 2025–26 (Ice Spice, Aguilera, Champion, Palm Angels).
  • Deleveraged balance sheet. >$2.7bn of debt eliminated; ~$1.5bn at emergence versus ~$3.4bn of funded debt at FY2021.
  • Professional franchises. CND Shellac and American Crew (70+ countries) provide salon-channel moats.

Weaknesses

  • Persistent losses. Net losses in every year FY2018–FY2022, totalling $1.95bn.
  • Negative free cash flow. Every year FY2019–FY2022; cumulative FCF -$487M.
  • Chronic under-investment. Capex of $10–29M a year (0.5–1.2% of sales).
  • Working-capital inefficiency. Cash conversion cycle of 132–215 days; DIO above 150 days.
  • Customer concentration. Walmart was 14–18% of sales.
  • Brand drift. The CEO admitted the Revlon brand had leaned toward "no-makeup makeup", contrary to its strengths (Glossy, 2026).
  • Transparency deficit. No financial reporting since FY2022, which limits counterparties' visibility.

Opportunities

  • Gen Z fragrance demand. The Ice Spice launch at Ulta (2026) and Juicy Couture format extensions.
  • Clean drugstore makeup. Almay targets this; management calls it a "little-exploited category".
  • Mass shelf-space gains. Peluso reports new space from the Revlon repositioning.
  • China localisation. Local R&D supports Elizabeth Arden's growth.
  • New licences. Champion and Palm Angels launch in 2027, adding sport and luxury-streetwear audiences.
  • Strategic exit. Credit-fund owners will eventually seek a sale or IPO. The brand-centric segment structure allows separable divestitures (Arden, CND, American Crew).

Threats

  • Litigation. Hair-relaxer MDL claims against chemical straightener makers; Revlon (Creme of Nature) was a named defendant pre-emergence, and the bar date was extended for these claimants in 2023.
  • Supply-chain fragility. The 2022 collapse shut plants in NC, Florida and Mexico; a recurrence would quickly hit liquidity again.
  • Licence dependency. Licensors can exit (AllSaints and Jennifer Aniston licences lapsed by end-2022).
  • Competitive intensity. e.l.f.'s rapid growth and L'Oréal's scale in mass colour.
  • China and travel-retail volatility. About 82% of Asia sales are Arden.
  • Residual leverage. About $1.5bn at emergence against FY2022 Adjusted EBITDA of $260M (~5.8x pro forma before any post-emergence improvement).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Ralph Marshall starts as Chief Information & Digital Officer, succeeding CIO Paul SmithDigital and data build-out
21 Apr 2025 (announced)Dana Medema named President, North America, effective 5 May 2025; Geralyn Breig exitsLeadership refresh in the largest region
Feb 2025 (approx.)David Schwartz appointed General CounselLegal leadership
2025 (approx. mid-year)Global fragrance licence with Ice Spice announced (Revlon Consumer Products LLC)First major celebrity fragrance deal in years
2025Christina Aguilera licence renewed; new scent planned for 2026Retains a core celebrity franchise
2025Juicy Couture licence renewed with Authentic Brands GroupSecures the top-selling fragrance licence
2025Champion global fragrance licence signed via ABG; launch 2027New licence pipeline
2025 (approx.)Plan to relocate New Jersey R&D lab to the NEST Center announcedR&D modernisation
Jan–Aug 2025D&B payment data: DBT 5–16; 25–37% of supplier payments 1–30 days lateLiquidity under control but not pristine
23 Oct 2025CosmeticsDesign "Financial Focus" profiles the turnaroundExternal validation of progress, with caveats
4 Nov 2025Peluso marks one year as CEO; portfolio-wide modernisation review (WWD)Strategy articulation
2025–2026"The Most Unforgettable Women in the World Wear Revlon" campaign ("newstalgia")Brand repositioning
Feb 2026Revlon PhotoReady relaunched with new packaging, shades and formulas for Gen ZFirst tangible output of the brand-identity work
23 Feb 2026Glossy interview: fragrance ~25% of sales; Palm Angels licence (2027); Elizabeth Arden Eternal Aura (2026); China R&D facility; supply-chain reframing; more mass shelf spaceMost detailed public strategy update
Jun–Jul 2026Revlon Professional promotes Color Excel by Revlonissimo Tone on Tone to the salon tradeProfessional-segment innovation
Aug–Sep 2026Ice Spice "In Ha Mood" launches at Ulta Beauty; NYC launch event (~9 Sep 2026)Key 2026 commercial test of the fragrance strategy
Sep 2026Former Revlon factory site in Maesteg (UK) slated for 190 homesLegacy asset disposal / redevelopment

Product Offering

  • Revlon, Inc.
    • Revlon Mascara
    • Sun Protection Products
    • Revlon

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Cost of sales fell from USD 1,052.2 Mn in FY2019 to USD 835.7 Mn in FY2022.
Revlon, Inc. — Income Statement: Revenue & Gross Profit
Series (USD Mn)FY2019FY2020FY2021FY2022
Cost of sales1,052.2860.5849.1835.7
Gross profit1,367.41,043.81,229.61,144.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.